Why JansBrief exists
Jan Stenbeck was the smartest person I ever met. Not smart in the way academics are smart. Smart in the way that changes the world. He saw what nobody else saw. He understood that mobile telephony would revolutionise countries that hadn't even laid copper wire yet. He broke state socialist monopolies when everyone said it was impossible. He built empires out of ideas.
Every day Jan received a binder. Two people read all the world's important newspapers and magazines for him and pulled out what mattered. The things others missed. The faint signals that foreshadow great change.
I worked with Jan. I learned from him. And I have never forgotten that binder. JansBrief is my tribute to him, a modern version: global, AI-driven, available to everyone with ambition.
In memory of Jan Stenbeck
1942 — 2002
Jan Stenbeck
Tele2, Millicom, MTG, Metro
In today's edition · 2 June 2026
A paper published today in Nature describes a machine-learning model that can measure your heart rate passively — in the background, while you scroll through Instagram or read the news — using nothing but your smartphone's front-facing camera. No wearable. No clinical visit. No conscious act of measurement. The system captures subtle colour changes in your face caused by blood flow, processes them through a neural network trained on hundreds of thousands of sessions, and estimates your resting heart rate with clinical-grade accuracy.
The research, conducted across a large population sample, shows the model works across skin tones, lighting conditions, and phone models. It doesn't require the user to hold still or press a finger to the lens. It simply watches while you do what you were already doing — and learns your cardiac baseline over time.
This isn't a fitness gadget story. It's a public-health infrastructure story. The cost of cardiac screening in low- and middle-income countries is prohibitive. Wearables like smart rings or smartwatches cost hundreds of dollars and require charging, pairing, and literacy in health-tech interfaces. A smartphone camera requires none of those things. There are an estimated 4.6 billion smartphones in active use globally. If even a fraction of those could serve as passive cardiac monitors, the implications for early detection of arrhythmia, hypertension and heart failure are enormous.
The model's design is deliberately lightweight. It doesn't need always-on processing or cloud computation — it can run inference locally, which matters both for battery life and for privacy. The researchers note that resting heart rate is one of the strongest independent predictors of cardiovascular mortality, yet most people have no idea what theirs is. Doctors measure it episodically, in clinical settings where anxiety inflates the reading. A passive model that captures resting heart rate during genuine rest — lying in bed reading, sitting on a bus — produces a more accurate and more useful number.
The privacy question is real and unavoidable. A phone that monitors your biometrics without active consent sits on a knife's edge between public good and surveillance. The researchers flag this, noting that the model was designed to process data locally and discard raw imagery. But once the capability exists, the governance question follows: who gets to deploy this, and on whose terms?
What makes this signal rather than noise is the convergence: the hardware already exists in billions of pockets, the AI model is small enough to run on-device, and the health need is universal. This isn't a prototype looking for a market. It's a market that has been waiting — silently, lethally — for a prototype.
Source: Nature · 1 June 2026
Now — Passive biometrics turn every phone into a clinical instrument: If this model ships inside Android or iOS health frameworks, passive heart-rate monitoring goes from a premium wearable feature to a default capability of any modern phone. That changes the denominator in global cardiac screening from "people who can afford a doctor" to "people who own a phone." Health systems in India, Nigeria, and Indonesia — where cardiovascular disease is the leading killer but screening infrastructure is threadbare — stand to benefit most. The gap between what technology can detect and what health systems can act on is about to widen dramatically — and the politics of that gap will define public-health debates for the next decade.
Soon — Insurance and pharma recalibrate around continuous data: The shift from episodic clinical measurement to continuous passive monitoring will force actuarial models to evolve. Insurers that today price cardiac risk on age, weight and family history will soon have access to longitudinal resting heart-rate data — a far more predictive signal. Pharmaceutical companies running cardiac drug trials will be able to gather real-world efficacy data at a fraction of current cost. The regulatory question — whether passively collected biometric data can serve as a clinical endpoint — will be tested within two years.
Later — The phone becomes the first point of care: Passive heart-rate monitoring is a waypoint, not a destination. Smartphone cameras can already detect respiratory rate, blood oxygen estimates, and atrial fibrillation signatures in research settings. As these models mature and combine, the phone evolves from a communication device into a continuous health-monitoring platform — a silent triage nurse. This shifts power away from hospital systems and toward individuals, but it also creates a new terrain for data exploitation. The countries and companies that get the governance right will define twenty-first-century public health. Those that don't will build the most intimate surveillance apparatus in history. Source: Nature · 1 June 2026 ---
Bangladesh's interim government is deepening ties with China as negotiations with India over Ganges and Teesta River water-sharing hit an impasse. Dhaka has signalled willingness to accept Chinese infrastructure financing for flood management and irrigation — projects India had long considered within its sphere of influence. The shift reflects both genuine frustration over decades of unresolved water disputes and a pragmatic calculation that Chinese capital comes with fewer political conditions. For New Delhi, the risk is strategic: losing its most important South Asian neighbour to a rival's orbit over a resource it could have shared. Source: Nikkei Asia · 1 June 2026
Africa Re, the continent's largest reinsurer, is making its boldest pitch yet: if African insurance companies pool their capacity instead of ceding premiums to Lloyd's of London and European reinsurers, the continent could absorb most of its own risk internally. CEO Corneille Karekezi argues that billions in premiums flow offshore annually, enriching foreign capital while leaving African markets underinsured. The proposal — a pan-African risk pool — would require regulatory harmonisation across dozens of jurisdictions, but the logic is compelling: why should African drought, flood and pandemic risk be priced in London? Source: The Africa Report · 1 June 2026
Lebanon announced that Hezbollah had agreed to a reciprocal halt in attacks on Israel, a development brokered with US involvement. Within hours, the Israeli military reported intercepting projectiles fired from Lebanon, and Hezbollah claimed attacks on Israeli forces in southern Lebanon. The collapse of the pause before it could properly begin underscores the structural difficulty: neither side has an incentive to stop first, and the US lacks the leverage to enforce compliance from both simultaneously. Source: BBC World · 1 June 2026
Facing the world's largest Alzheimer's and Parkinson's patient population — projected to hit 10.5 million Parkinson's cases alone by 2050 — China is accelerating drug development and explicitly incorporating traditional Chinese medicine compounds into its research pipeline. It's a high-stakes bet: if TCM-derived molecules survive rigorous clinical trials, China gains both a therapeutic and a soft-power advantage. If they don't, the programme risks diverting resources from proven approaches during a demographic emergency. Source: South China Morning Post · 1 June 2026
Mette Frederiksen, the centre-left Danish prime minister who became a global figure by publicly defying Donald Trump over Greenland, has announced a new government after weeks of gruelling coalition negotiations. The deal keeps Frederiksen in power for an unprecedented third consecutive term but requires concessions to junior partners on immigration and defence spending. For the EU, her survival matters: Denmark under Frederiksen has become an unexpectedly assertive voice on Arctic sovereignty and transatlantic relations at a moment when both are under strain. Source: Politico Europe · 1 June 2026
China's liquefied natural gas imports rebounded sharply in May as the world's largest buyer stepped up purchases ahead of peak summer demand, reversing a months-long decline triggered by disruptions to Middle East supply routes. The surge signals that Chinese industrial activity — and air-conditioning load — is running hotter than bearish forecasts suggested. For global LNG markets, the timing is awkward: European storage is below seasonal averages, Australia's export terminals face maintenance shutdowns, and new Qatari capacity won't flow until late 2027. Two of the world's biggest buyers are now competing for the same constrained supply heading into the hottest months of the year. Source: Bloomberg · 1 June 2026
European Union negotiators have reached agreement on a controversial new returns regulation that would allow member states to send migrants who have been ordered to leave EU territory to designated "return hubs" in third countries. The deal, pushed hardest by France and Italy, marks the most significant shift in EU migration policy in a decade. Critics warn it outsources asylum obligations to countries with poor human-rights records; supporters say the current system — where fewer than 20% of deportation orders are enforced — is functionally broken. The law will face a final vote in the European Parliament this autumn. Source: Politico Europe · 1 June 2026
Japan is slipping toward a banana shortage, and the cause is geopolitical, not agricultural. The country imports bananas green and ripens them in ethylene-filled rooms before sale. Ethylene is derived from naphtha, which comes from crude oil — more than 90% of it imported. With Middle East supply disruptions tightening naphtha availability, the ripening infrastructure is faltering. It's a small, absurd illustration of a large, serious truth: food systems in import-dependent economies are only as resilient as their most obscure input. Source: South China Morning Post · 1 June 2026 ---
India and the UAE have struck an agreement that sidesteps the usual playbook for AI infrastructure. Under the deal, Abu Dhabi-based G42 will deploy US-designed supercomputers on Indian soil, giving New Delhi something it has long sought: sovereign control over the hardware that runs its AI ambitions, without having to build the chips or design the systems itself.
The arrangement is a triangulation. The chips are American — advanced Nvidia GPUs cleared under US export rules. The integration and deployment come through G42, which has deep ties to both Abu Dhabi's sovereign wealth apparatus and, increasingly, to Washington. And the data stays in India, processed on Indian territory under Indian jurisdiction.
What makes this remarkable is the model it represents. For years, the assumption in AI geopolitics has been binary: either you build your own stack (as China is attempting, painfully, after US export controls) or you rent capacity from American hyperscalers — Microsoft Azure, Amazon Web Services, Google Cloud — and accept the dependency that comes with it. India has found a third path: import the hardware through a Gulf intermediary, own the physical infrastructure, and retain data sovereignty.
The strategic logic is clear. India's AI ambitions — from agricultural yield prediction to Aadhaar-linked public services — require massive compute. But routing that compute through American cloud providers means Indian citizens' data transits servers governed by US law, including potential surveillance obligations. By placing US-designed hardware inside Indian borders through a UAE partner, India gets the performance without the jurisdictional exposure.
The deal also reveals something about the UAE's evolving role. Abu Dhabi is positioning itself not as an AI power in its own right — it lacks the population and data scale — but as an AI broker: a trusted intermediary that can move American technology to non-aligned countries without triggering Washington's export-control anxieties. It's a new kind of middle-power diplomacy, conducted in silicon rather than diplomacy cables.
Jan would have liked this because it's a quiet act of architectural cleverness — a country solving a hard problem not by confrontation or capitulation, but by redesigning the geometry of the deal. That's the kind of pragmatism that builds lasting power.
Source: Rest of World · 1 June 2026
Charlie Brooker's *Black Mirror* universe has escaped the screen. An immersive theatrical experience inspired by the series has opened at the Shed in Manhattan, following its debut at Cannes last month. Audiences move through interconnected rooms designed to replicate the show's signature blend of sleek technology and psychological dread — part escape room, part art installation, part controlled panic attack. It's the latest bid by a streaming franchise to convert screen loyalty into physical experience, and the most ambitious: the Shed's cavernous spaces allow set design at a scale that smaller immersive venues can't match. Whether it's art or IP exploitation depends on which room you're standing in. Source: Artnet News · 1 June 2026
Safdie Architects has finished a major expansion of the Crystal Bridges Museum of American Art in Bentonville, Arkansas — adding two galleries and over 10,500 square metres of space. The new structures maintain the original building's dialogue with the Ozark landscape while departing from its signature barrel-vaulted forms. Bentonville, population 60,000, already punches absurdly above its weight as an art destination (thanks to Walmart heiress Alice Walton's patronage). The expansion cements its claim as America's most improbable cultural capital. Source: Dezeen · 1 June 2026
A curated selection of works by Tarsila do Amaral — Brazil's most important modernist painter — from her celebrated 1920s golden phase will be offered for sale at Art Basel Paris in October. The works, spanning the period that produced *Abaporu* and *A Negra*, rarely appear on the market. For a painter who defined Brazilian visual identity as decisively as Picasso defined Cubism, any public offering is an event. The prices will be in the millions, but the cultural weight is incalculable. Source: Folha de São Paulo · 1 June 2026
A new exhibition in Prague reveals a hidden chapter of architectural history: modest countryside cottages in postwar Czechoslovakia that became unlikely laboratories for avant-garde design. These weren't grand commissions. They were weekend retreats where architects experimented freely, applying modernist principles to tiny budgets and rural materials. The show argues that some of the most radical spatial ideas of the twentieth century emerged not from metropolitan studios but from the constraints of the countryside. Source: Wallpaper · 1 June 2026
Forget the usual circuit. Monocle reports that talent scouts are increasingly heading to Helsinki, where Aalto University's fashion programme is producing a generation of designers who combine technical garment-making with Nordic self-expression. Finland's fashion renaissance is rooted in craft, not marketing — graduates know how to cut, sew and construct before they learn to brand. In an industry drowning in concept and starving for competence, that's a competitive edge. Source: Monocle · 1 June 2026
Rem Koolhaas's OMA has completed Hangzhou Prism, a 43,000-square-metre mixed-use building with a pyramidal silhouette that incorporates a public square at its base. The asymmetric form — housing hotel rooms, apartments, offices, and public space — is designed as a "three-dimensional village." In a Chinese cityscape dominated by glass towers and copycat supertalls, the building's refusal to be tall and its insistence on public ground-level space feels almost subversive. Source: Dezeen · 1 June 2026 ---
The state of Florida has filed a lawsuit against OpenAI and its CEO, alleging that the company's chatbots have caused a "litany of harms" to children. The suit — one of the first by a US state directly targeting a large-language-model provider — claims that OpenAI's products exposed minors to inappropriate content, manipulative interactions, and psychological harm without adequate safeguards. The legal theory is aggressive: rather than targeting a social-media platform for addictive design (the playbook used against Meta and TikTok), Florida is arguing that the conversational AI itself is the product causing injury — that a system designed to be maximally responsive and human-like is inherently dangerous when a child is the user. If the case proceeds, it could establish the first legal precedent defining a chatbot maker's duty of care to minors. For the AI industry, the timing is brutal: it arrives just as Anthropic files for its IPO and the sector is trying to project maturity and trustworthiness to public markets. Source: Financial Times · 1 June 2026
New Scientist reports that an experimental daily pill for advanced pancreatic cancer has doubled median survival time compared to standard chemotherapy infusions in clinical trials. The drug — described as "transformative" by oncologists — targets a specific molecular pathway in pancreatic tumours, which have long had the worst prognosis of any major cancer. Pancreatic cancer's five-year survival rate has barely moved in decades, hovering around 12%. A drug that doubles survival time doesn't cure the disease, but it moves the needle more than anything in a generation. Equally significant: it's a pill, not an infusion, which means it can be administered outside hospital settings — a critical factor for health systems in low-resource countries where oncology infrastructure is sparse. Source: New Scientist · 1 June 2026
Mach Industries, the defence-technology startup led by 22-year-old founder Ethan Thornton, has raised $300 million at a $1.8 billion valuation — a fourfold jump in a single year. The company, which is developing five autonomous military vehicles simultaneously and recently completed a major acquisition, sits at the intersection of two powerful currents: the Pentagon's growing appetite for unmanned systems and Silicon Valley's rediscovery that defence contracts offer the kind of durable, government-backed revenue that consumer tech cannot. What's striking is the speed: Mach has gone from seed-stage startup to near-unicorn in a timeframe that would have been extraordinary even during the software boom. The valuation reflects a bet that the next generation of military hardware will be designed by startups, not legacy contractors — and that the regulatory barriers that once protected Lockheed and Raytheon are eroding faster than anyone expected. Source: TechCrunch · 1 June 2026 ---
55,000
55,000
That's the number of cancer cases left undiagnosed across seven nations during the Covid-19 pandemic, according to a new study reported in the Straits Times. The figure — covering countries including the UK, Australia, and several European nations — represents patients whose cancers progressed undetected while health systems were overwhelmed by Covid. The implications are still unfolding: late-stage diagnoses mean worse outcomes, higher treatment costs, and shorter lives. But the number also carries a forward-looking lesson. Today's signal — passive health monitoring via smartphone cameras — speaks directly to this gap. The pandemic revealed that health systems built on clinic-based screening collapse when clinics close. A world in which cardiac risk, respiratory patterns, and potentially other biomarkers can be monitored passively and continuously through devices people already own is a world less vulnerable to the next pandemic's collateral damage. The 55,000 undiagnosed cases are not just a historical tragedy. They are the business case for ambient health surveillance — and the moral argument for getting its governance right before the next crisis, not after.
Source: Straits Times · 1 June 2026
In perspective
That's the number of cancer cases left undiagnosed across seven nations during the Covid-19 pandemic, according to a new study reported in the Straits Times. The figure — covering countries including the UK, Australia, and several European nations —...
8 — Today's Wisdom
India just solved a problem that most countries haven't even realized they have. By letting the United Arab Emirates act as an intermediary for American AI hardware, New Delhi got supercomputers on its own soil, under its own jurisdiction, without either manufacturing the chips themselves or handing their data over to American cloud giants. This isn't diplomacy in the traditional sense. It's architecture, in the most concrete meaning of the word.
I've built three companies that reached billion-dollar valuations, and the most important lesson from all three is the same: you don't need to own every component in the chain, but you must own the part that determines who has control. India understood that. They could have done what most countries do and rented capacity from Amazon or Microsoft, convenient and fast, but that kind of convenience comes with a dependency that never shows up in the contract — only when it's too late.
The fascinating thing is that the model is replicable. Small and mid-sized countries like Sweden are in exactly the same position. We have AI ambitions, we have data, we have talent. But we have no domestic chip production and no hyperscaler. The question is whether we have the courage to design our own geometry for digital independence, or whether we settle for being tenants in someone else's infrastructure. India chose to be the host. We should too.
Johan Staël von Holstein
Serial entrepreneur · wakopa.ai